These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8809656

  • 1. Intermittent continuous infusion of 5-fluorouracil in combination with epirubicin and cisplatin in advanced gastric cancer: the importance of dose intensity.
    Poorter RL, Bakker PJ, Fockens P, Taat CW, Bartelsman JF, Veenhof CH.
    J Infus Chemother; 1996; 6(2):87-91. PubMed ID: 8809656
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.
    Cancer; 2001 Jun 15; 91(12):2288-93. PubMed ID: 11413517
    [Abstract] [Full Text] [Related]

  • 3. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
    Bamias A, Hill ME, Cunningham D, Norman AR, Ahmed FY, Webb A, Watson M, Hill AS, Nicolson MC, O'Brien ME, Evans TC, Nicolson V.
    Cancer; 1996 May 15; 77(10):1978-85. PubMed ID: 8640659
    [Abstract] [Full Text] [Related]

  • 4. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Tsuji A, Morita S, Horimi T, Takasaki M, Takahashi I, Shirasaka T.
    Gan To Kagaku Ryoho; 1999 Jun 15; 26(7):933-8. PubMed ID: 10396320
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL, Yeh KH, Lin JT, Hsu C, Liu MY.
    Anticancer Res; 1998 Jun 15; 18(2B):1267-72. PubMed ID: 9615799
    [Abstract] [Full Text] [Related]

  • 6. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS, Moon DH, Shim BY, Lee MA, Byun JH, Kim KW, Kang JH, Choi MG, Chung IS, Hong YS, Park SY, Lee KS.
    Jpn J Clin Oncol; 2005 Jan 15; 35(1):13-7. PubMed ID: 15681598
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M, Mambrini A, Fiorentini G, Rabbi C, Zamagni D, Caudana R, Pennucci C, Sanguinetti F, Lombardi M, Nicoli N.
    Cancer; 2005 Apr 01; 103(7):1402-7. PubMed ID: 15726542
    [Abstract] [Full Text] [Related]

  • 9. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y, Shu Y, Xu Q.
    Biomed Pharmacother; 2009 May 01; 63(4):293-6. PubMed ID: 18848761
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC).
    Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M.
    Hepatogastroenterology; 2008 May 01; 55(85):1380-4. PubMed ID: 18795694
    [Abstract] [Full Text] [Related]

  • 11. Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.
    Thuss-Patience PC, Kretzschmar A, Repp M, Kingreen D, Hennesser D, Micheel S, Pink D, Scholz C, Dörken B, Reichardt P.
    J Clin Oncol; 2005 Jan 20; 23(3):494-501. PubMed ID: 15659494
    [Abstract] [Full Text] [Related]

  • 12. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P.
    J Infus Chemother; 1996 Jan 20; 6(3):149-51. PubMed ID: 9229328
    [Abstract] [Full Text] [Related]

  • 13. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
    Chung YS, Yamashita Y, Inoue T, Matsuoka T, Nakata B, Onoda N, Maeda K, Sawada T, Kato Y, Shirasaka T, Sowa M.
    Cancer; 1997 Jul 01; 80(1):1-7. PubMed ID: 9210702
    [Abstract] [Full Text] [Related]

  • 14. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
    Kim R, Murakami S, Ohi Y, Inoue H, Yoshida K, Toge T.
    Int J Oncol; 1999 Nov 01; 15(5):921-6. PubMed ID: 10536174
    [Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
    Tsuji A, Morita S, Horimi T, Takasaki M, Takahashi I, Shirasaka T.
    Gan To Kagaku Ryoho; 2000 May 01; 27 Suppl 2():528-34. PubMed ID: 10895205
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.
    Kim YH, Shin SW, Kim BS, Kim JH, Kim JG, Mok YJ, Kim CS, Rhyu HS, Hyun JH, Kim JS.
    Cancer; 1999 Jan 15; 85(2):295-301. PubMed ID: 10023695
    [Abstract] [Full Text] [Related]

  • 17. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Beerblock K, Rinaldi Y, André T, Louvet C, Raymond E, Tournigand C, Carola E, Favre R, de Gramont A, Krulik M.
    Cancer; 1997 Mar 15; 79(6):1100-5. PubMed ID: 9070486
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
    Idelevich E, Karminsky N, Dinerman M, Katsenelson RL, Zvi NB, Baruch NB, Biran H, Man S, Shani A.
    Acta Oncol; 2007 Mar 15; 46(3):324-9. PubMed ID: 17450467
    [Abstract] [Full Text] [Related]

  • 19. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
    Lim JY, Cho JY, Oh KJ, Choi SH, Lee SI, Jeung HC.
    Chemotherapy; 2009 Mar 15; 55(4):200-6. PubMed ID: 19451710
    [Abstract] [Full Text] [Related]

  • 20. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer.
    Oh SY, Kwon HC, Seo BG, Kim SH, Kim JS, Kim HJ.
    Acta Oncol; 2007 Mar 15; 46(3):336-41. PubMed ID: 17450469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.